|
|
![]() | ![]() | ![]() | ![]() |
This excerpt taken from the THRX 10-K filed Mar 10, 2006. Stock-based
compensation. Stock-based compensation expense
decreased to $5.6 million in 2005 from $8.5 million in 2004. These amounts
reflect the amortization of deferred stock-based compensation, much of which
was recorded in 2004 and 2003. In 2005 we recorded deferred stock-based
compensation of $0.9 million related to the grant of restricted stock of which
$0.2 million was amortized in 2005. We anticipate that these amounts will
increase significantly in 2006 and beyond due to the impact of expensing stock
options in accordance with FASB Statement No. 123 (revised 2004) Share-Based
Payment (see further discussion under Recent Accounting Pronouncements
below), which is effective beginning in the first quarter of 2006. It is likely
that we will adopt the modified prospective application method and the Black
Scholes valuation model to determine the fair value of our stock as provided by
the provisions of SFAS 123(R). In 2004 we recorded deferred stock-based
compensation of $17.4 million for stock options granted in 2004 at prices
below the deemed fair value of our common stock on the option grant dates.
Stock-based compensation expense increased to $8.5 million in 2004 from
$2.2 million in 2003. These amounts reflect the amortization of deferred
stock-based compensation, much of which was recorded in 2004 and 2003.
This excerpt taken from the THRX 10-K filed Mar 8, 2006. Stock-based
compensation. Stock-based compensation expense decreased
to $5.6 million in 2005 from $8.5 million in 2004. These amounts reflect
the amortization of deferred stock-based compensation, much of which was
recorded in 2004 and 2003. In 2005 we recorded deferred stock-based
compensation of $0.9 million related to the grant of restricted stock of which
$0.2 million was amortized in 2005. We anticipate that these amounts will
increase significantly in 2006 and beyond due to the impact of expensing stock
options in accordance with FASB Statement No. 123 (revised 2004)
Share-Based Payment (see further discussion under Recent Accounting
Pronouncements below), which is effective beginning in the first quarter of
2006. It is likely that we will adopt the modified prospective application
method and the Black Scholes valuation model to determine the fair value of our
stock as provided by the provisions of SFAS 123(R). In 2004 we recorded
deferred stock-based compensation of $17.4 million for stock options
granted in 2004 at prices below the deemed fair value of our common stock on
the option grant dates. Stock-based compensation expense increased to $8.5
million in 2004 from $2.2 million in 2003. These amounts reflect the
amortization of deferred stock-based compensation, much of which was recorded
in 2004 and 2003.
This excerpt taken from the THRX 10-Q filed Nov 14, 2005. Stock-based
compensation
Employee and non-employee stock-based compensation expense decreased to
$1.1 million and $3.9 million for the three and nine months ended September 30,
2005, respectively, from $2.3 million and $6.2 million for the three and
nine months ended September 30, 2004, respectively. These amounts reflect the
amortization of deferred stock-based compensation, much of which was recorded
in the years ended December 31, 2004 and 2003. For the nine months ended September 30, 2005
we recorded deferred stock-based compensation of $0.9 million related to the
grant of restricted stock of which $0.2 million was amortized for the nine
months ended September 30, 2005. For the three and nine months ended September
30, 2004, we recorded deferred stock-based compensation of $2.9 million and
$19.5 million, respectively, for stock options granted in 2004 at prices below
the deemed fair value on the option grant dates.
This excerpt taken from the THRX 10-Q filed Aug 12, 2005. Stock-based
compensation
Employee and non-employee stock-based compensation expense decreased to
$1.4 million and $2.8 million for the three and six months ended June 30,
2005, respectively, from $3.5 million and $3.9 million for the three and
six months ended June 30, 2004, respectively. These amounts reflect the
amortization of deferred stock-based compensation, much of which was recorded
in the years ended December 31, 2004 and 2003. For the six months ended June 30, 2005
we recorded deferred stock-based compensation of $0.9 million related to the
grant of restricted stock of which $0.1 million was amortized for the six
months ended June 30, 2005. For the six months ended June 30, 2004,
we recorded deferred stock-based compensation of $16.6 million, for stock
options granted in 2004 at prices below the deemed fair value on the option
grant dates.
This excerpt taken from the THRX 10-Q filed May 13, 2005. Stock-based compensation Employee and non-employee stock-based
compensation expense increased to $1.4 million for the three months ended March 31,
2005 from $385,000 for the three months ended March 31, 2004. These
amounts reflect the amortization of deferred stock-based compensation, much of
which was recorded in the years ended December 31, 2004 and 2003. For the three months ended March 31,
2005 we recorded deferred stock-based compensation of $896,000 related to the
grant of restricted stock of which $19,000 was recognized as a period expense.
For the three months ended March 31, 2004 we recorded no deferred
stock-based compensation.
This excerpt taken from the THRX 10-K filed Mar 29, 2005. Stock-based compensation. Stock-based
compensation expense increased to $8.5 million in 2004 from $2.2 million
in 2003. These amounts reflect the amortization of deferred stock-based
compensation, much of which was recorded in 2004 and 2003. In 2004 we recorded
deferred stock-based compensation of $17.4 million for stock options
granted in 2004 at prices below the deemed fair value of our common stock on
the option grant dates. Stock-based compensation expense declined to
$2.2 million in 2003 from $4.9 million in 2002, reflecting higher
amortization of expense for deferred stock-based compensation recorded in
earlier periods under the accelerated method.
| EXCERPTS ON THIS PAGE:
RELATED TOPICS for THRX: |
| |||||||